{"id":11475,"date":"2020-04-13T17:39:23","date_gmt":"2020-04-13T21:39:23","guid":{"rendered":"https:\/\/cahr.wpengine.com\/?post_type=virtual_conferences&p=11475"},"modified":"2020-05-04T16:25:21","modified_gmt":"2020-05-04T20:25:21","slug":"presentation-orale-dabreges","status":"publish","type":"virtual_conferences","link":"https:\/\/www.cahr-acrv.ca\/fr\/virtual_conferences\/presentation-orale-dabreges\/","title":{"rendered":"Pr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s"},"content":{"rendered":"

\"\"<\/p>\n

Cliquer sur le num\u00e9ro de programme pour consulter les r\u00e9sum\u00e9s.<\/p>\n

Sciences Fondamentales<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n
BS2.01<\/a><\/strong><\/td>\nCharacterization of HIV Reservoirs in Multiple Tissues Collected Post-mortem from Two Individuals on Suppressive ART<\/a><\/td>\n<\/tr>\n
BS2.02<\/a><\/strong><\/td>\nPulmonary mucosal double negative T cells as HIV reservoirs during long-term ART<\/a><\/td>\n<\/tr>\n
BS2.03<\/a><\/strong><\/td>\nPlasma CXCL13 Correlates with Reservoir Size in Long-term ART-treated People Living With HIV<\/a><\/td>\n<\/tr>\n
BS2.05<\/a><\/strong><\/td>\nHiv-1 Nef Enhances Viral Reactivation from Latency by Stimulating TNF-\u03b1 Expression<\/a><\/td>\n<\/tr>\n
BS3.01<\/a><\/strong><\/td>\nProductively-Infected Cd4 T Cells are Resistant to Non-neutralizing Antibodies<\/a><\/td>\n<\/tr>\n
BS3.02<\/a><\/strong><\/td>\nLatency Reversing Agents: impact on Human Macrophages Susceptibility to HIV-1 Infection and Viral Production<\/a><\/td>\n<\/tr>\n
BS3.05<\/a><\/strong><\/td>\nFrequencies and Correlates of Endocervical Regulatory T Cells (Treg) Amongst HIV Seronegative Female Sex Workers (FSWs) in Nairobi<\/a><\/td>\n<\/tr>\n
BS4.01<\/a><\/strong><\/td>\nNef Inhibitors as Adjuvants Towards a Cure for HIV\/AIDS<\/a><\/td>\n<\/tr>\n
BS4.02<\/a><\/strong><\/td>\nDynamics of regulatory and effector CD8 T-cells in mesenteric lymph nodes and blood during SIV infection of Rhesus Macaques and following early ART initiation<\/a><\/td>\n<\/tr>\n
BS4.03<\/a><\/strong><\/td>\nImpact of Early Antiretroviral Therapy on B and CD4 T Cell Dynamics in Lymphoid Tissues of SIV Infected Rhesus Macaques<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Sciences Cliniques<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n
CS1.01<\/a><\/strong><\/td>\nNeurodevelopmental and Mental Health Co-morbidities in Canadian Children and Adolescents Living with HIV in the EPIC4 cohort<\/a><\/td>\n<\/tr>\n
CS1.02<\/a><\/strong><\/td>\nDouble Trouble: Increased Risk of Congenital Cytomegalovirus Infection Among HIV-exposed Newborns<\/a><\/td>\n<\/tr>\n
CS1.05<\/a><\/strong><\/td>\nReproductive Toxicity Studies to Evaluate Potential Neural Tube and Other Abnormalities Associated with Dolutegravir Exposure in Pregnancy<\/a><\/td>\n<\/tr>\n
CS3.02<\/a><\/strong><\/td>\nEffect of Metformin Treatment on Non-Diabetic HIV-Infected Individuals on ART<\/a><\/td>\n<\/tr>\n
CS3.03<\/a><\/strong><\/td>\nDeclining Prevalence of Drug Interactions Between Antiretroviral and Other Drugs in Antiretroviral Therapy (ART)-Treated Persons in British Columbia (BC), 2010-2016<\/a><\/td>\n<\/tr>\n
CS3.04<\/a><\/strong><\/td>\nUntimed Plasma Efavirenz Levels after Switching from Brand to Generic Formulations<\/a><\/td>\n<\/tr>\n
CS3.05<\/a><\/strong><\/td>\nUtility of HIV Drug Resistance Testing in Low Viral Load Samples<\/a><\/td>\n<\/tr>\n
CS4.01<\/a><\/strong><\/td>\nEffectiveness of an Intervention to Reengage HIV-Positive Patients Into Care (Lost & Found)<\/a><\/td>\n<\/tr>\n
CS4.02<\/a><\/strong><\/td>\nSyndemic Effects of Childhood Adverse Experiences, Depression, and Substance Use on Antiretroviral Non-adherence among Participants of the OHTN Cohort Study<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00c9pid\u00e9miologie et Siences de la Sant\u00e9 Publique<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n
EPH1.01<\/a><\/strong><\/td>\nUsing Administrative Pharmaceutical Prescription Data to Estimate the Number of Persons on HIV Antiretroviral Treatment, Canada, 2014\u20132018<\/a><\/td>\n<\/tr>\n
EPH1.02<\/a><\/strong><\/td>\nA Novel Phylogenetic Approach to Prioritizing HIV-1 Transmission Clusters<\/a><\/td>\n<\/tr>\n
EPH1.03<\/a><\/strong><\/td>\nUsing Population-level Latent Class Analysis to Classify People Living with HCV in British Columbia (BC) for Targeted Program Planning<\/a><\/td>\n<\/tr>\n
EPH1.05<\/strong><\/a><\/td>\nHepatitis C Virus (HCV) Treatment, Injection Practices, and Access to Harm Reduction among HIV-HCV co-infected People who Inject Drugs in Montr\u00e9al from 2003-2018<\/a><\/td>\n<\/tr>\n
EPH2.02<\/a><\/strong><\/td>\nDepression is associated with bacterial sexually transmitted infections (STIs) among gay, bisexual, and other men who have sex with men (gbMSM)<\/a><\/td>\n<\/tr>\n
EPH2.07<\/a><\/strong><\/td>\nScale-up and Sustainability of Digital Public Health Services for STBBI Testing: an Investigation of Healthcare Service and HIV Policy Context in British Columbia<\/a><\/td>\n<\/tr>\n
EPH3.02<\/strong><\/a><\/td>\nSporadic Clustered Outbreaks of HIV Among MSM Persist in Treatment-as-Prevention Era<\/a><\/td>\n<\/tr>\n
EPH3.03<\/strong><\/a><\/td>\nShort-Term Impacts of the Ph\u00e9nix Program: a Promising Community-Based Intervention to Improve gbMSM\u2019s Sexual Health and Wellbeing<\/a><\/td>\n<\/tr>\n
EPH4.02<\/a><\/strong><\/td>\nPrEP uptake amongst MSM accessing sexual health services in Ontario and British Columbia \u2013 Results of the PrIMP Community Survey<\/a><\/td>\n<\/tr>\n
EPH4.05<\/a><\/strong><\/td>\nUptake of PrEP among Users of Non-occupational PEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montr\u00e9al (2013 \u2013 2019)<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Sciences Sociales<\/h4>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n
SS1.02<\/a><\/strong><\/td>\nRecent developments in Canada’s approach to HIV criminalization : The role of the Canadian Coalition to Reform HIV Criminalization in fostering change<\/a><\/td>\n<\/tr>\n
SS2.01<\/a><\/strong><\/td>\n\u201cPeople Give and Take a Lot in Order to Participate in Things:\u201d\u00a0 Making a Case for Non-participation in HIV CBPR and Participatory Programming with Young People<\/a><\/td>\n<\/tr>\n
SS3.02<\/a><\/strong><\/td>\nMaking \u201cRisk\u201d Visible in Perinatal Care for Mothers Living with HIV in Ontario: An Institutional Ethnography<\/a><\/td>\n<\/tr>\n
SS3.06<\/a><\/strong><\/td>\nSocial Support and STBBI Transmission Behaviours Among HIV-Negative Gay, Bisexual, and Other Men Who Have Sex with Men (GBM)<\/a><\/td>\n<\/tr>\n
SS4.04<\/a><\/strong><\/td>\nPeer Health Advocacy Wellness Network (PHAWN): Commencing a Network of Peers within First Nations Communities in Saskatchewan<\/a><\/td>\n<\/tr>\n
SSKP1.02<\/a><\/strong><\/td>\nBarriers to access to antiretroviral treatment and care for people living with HIV with precarious immigration status<\/a><\/td>\n<\/tr>\n
SSKP1.03<\/a><\/strong><\/td>\nCelebrate: Love, Laugh & Live Together (Celebrate: 3LT). an Inter-generational Exploration of Grief and Loss Through Story-making<\/a><\/td>\n<\/tr>\n
SSKP4.02<\/strong><\/a><\/td>\nHow Does HIV Optimism Feature Within the Perspectives and Experiences of Young Sexual and Gender Minority Men? A Discourse Analysis<\/a><\/td>\n<\/tr>\n
SSKP4.06<\/a><\/strong><\/td>\nThe role of perceived discrimination on suicidal ideation among gay, bisexual and other men who have sex with men in Montreal<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Populations Cl\u00e9s<\/h4>\n\n\n\n\n\n\n\n\n
KP1.01<\/a><\/strong><\/td>\nSuccesses and Challenges in Empowerment Strategies amongst Newcomer PHAs: Insights from the Ethno-racial Treatment Support Network Training Evaluation Study<\/a><\/td>\n<\/tr>\n
KP2.03<\/a><\/strong><\/td>\nTracks Survey of people who inject drugs in Canada, Phase 4 2017-2019 \u2013 Selected findings among Indigenous participants<\/a><\/td>\n<\/tr>\n
KP2.04<\/a><\/strong><\/td>\nCulturally Specific and Gender Based STBBI Interventions Designed by and for Incarcerated Indigenous Women<\/a><\/td>\n<\/tr>\n
KP3.01<\/a><\/strong><\/td>\n\u201cI felt safe there\u201d: Implications of an Acute Care Supervised Consumption Service for the Hospital Risk Environment<\/a><\/td>\n<\/tr>\n
KP3.02<\/a><\/strong><\/td>\nHIV and HCV Cascade of Care Among People Who Inject Drugs in the SurvUDI Network \u2013 2003 to 2017<\/a><\/td>\n<\/tr>\n
KP4.01<\/a><\/strong><\/td>\nPreliminary results of the Dual Daily HIV and Syphilis Pre-Exposure Prophylaxis (DuDHS) Trial.<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Cliquer sur le num\u00e9ro de programme pour consulter les r\u00e9sum\u00e9s. Sciences Fondamentales BS2.01 Characterization of HIV Reservoirs in Multiple Tissues Collected Post-mortem from Two Individuals on Suppressive ART BS2.02 Pulmonary mucosal double negative T cells as HIV reservoirs during long-term ART BS2.03 Plasma CXCL13 Correlates with Reservoir Size in Long-term ART-treated People Living With HIV […]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":3,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-11475","virtual_conferences","type-virtual_conferences","status-publish","hentry"],"acf":[],"yoast_head":"\nPr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s – ACRV<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s – ACRV\" \/>\n<meta property=\"og:description\" content=\"Cliquer sur le num\u00e9ro de programme pour consulter les r\u00e9sum\u00e9s. Sciences Fondamentales BS2.01 Characterization of HIV Reservoirs in Multiple Tissues Collected Post-mortem from Two Individuals on Suppressive ART BS2.02 Pulmonary mucosal double negative T cells as HIV reservoirs during long-term ART BS2.03 Plasma CXCL13 Correlates with Reservoir Size in Long-term ART-treated People Living With HIV […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/\" \/>\n<meta property=\"og:site_name\" content=\"ACRV\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-04T20:25:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@CAHR_ACRV\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/\",\"url\":\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/\",\"name\":\"Pr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s – ACRV\",\"isPartOf\":{\"@id\":\"https:\/\/www.cahr-acrv.ca\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png\",\"datePublished\":\"2020-04-13T21:39:23+00:00\",\"dateModified\":\"2020-05-04T20:25:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#primaryimage\",\"url\":\"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png\",\"contentUrl\":\"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.cahr-acrv.ca\/fr\/accueil\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cahr-acrv.ca\/#website\",\"url\":\"https:\/\/www.cahr-acrv.ca\/\",\"name\":\"ACRV\",\"description\":\"L'association canadienne de recherche sur le VIH\",\"publisher\":{\"@id\":\"https:\/\/www.cahr-acrv.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cahr-acrv.ca\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cahr-acrv.ca\/#organization\",\"name\":\"Canadian Association for HIV Research\",\"alternateName\":\"CAHR\",\"url\":\"https:\/\/www.cahr-acrv.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.cahr-acrv.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2025\/06\/cahr-organization-logo.png\",\"contentUrl\":\"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2025\/06\/cahr-organization-logo.png\",\"width\":696,\"height\":696,\"caption\":\"Canadian Association for HIV Research\"},\"image\":{\"@id\":\"https:\/\/www.cahr-acrv.ca\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch\",\"https:\/\/x.com\/CAHR_ACRV\",\"https:\/\/bsky.app\/profile\/cahr-acrv.bsky.social\",\"https:\/\/www.youtube.com\/user\/CAHRACRV\",\"https:\/\/www.instagram.com\/cahr_acrv\/\",\"https:\/\/www.linkedin.com\/company\/canadian-association-for-hiv-research\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s – ACRV","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/","og_locale":"fr_FR","og_type":"article","og_title":"Pr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s – ACRV","og_description":"Cliquer sur le num\u00e9ro de programme pour consulter les r\u00e9sum\u00e9s. Sciences Fondamentales BS2.01 Characterization of HIV Reservoirs in Multiple Tissues Collected Post-mortem from Two Individuals on Suppressive ART BS2.02 Pulmonary mucosal double negative T cells as HIV reservoirs during long-term ART BS2.03 Plasma CXCL13 Correlates with Reservoir Size in Long-term ART-treated People Living With HIV […]","og_url":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/","og_site_name":"ACRV","article_publisher":"https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch","article_modified_time":"2020-05-04T20:25:21+00:00","og_image":[{"url":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@CAHR_ACRV","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/","url":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/","name":"Pr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s – ACRV","isPartOf":{"@id":"https:\/\/www.cahr-acrv.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#primaryimage"},"image":{"@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png","datePublished":"2020-04-13T21:39:23+00:00","dateModified":"2020-05-04T20:25:21+00:00","breadcrumb":{"@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#primaryimage","url":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png","contentUrl":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/presentation-orale-dabreges\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.cahr-acrv.ca\/fr\/accueil\/"},{"@type":"ListItem","position":2,"name":"Pr\u00e9sentation orale d\u2019abr\u00e9g\u00e9s"}]},{"@type":"WebSite","@id":"https:\/\/www.cahr-acrv.ca\/#website","url":"https:\/\/www.cahr-acrv.ca\/","name":"ACRV","description":"L'association canadienne de recherche sur le VIH","publisher":{"@id":"https:\/\/www.cahr-acrv.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cahr-acrv.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cahr-acrv.ca\/#organization","name":"Canadian Association for HIV Research","alternateName":"CAHR","url":"https:\/\/www.cahr-acrv.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cahr-acrv.ca\/#\/schema\/logo\/image\/","url":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2025\/06\/cahr-organization-logo.png","contentUrl":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2025\/06\/cahr-organization-logo.png","width":696,"height":696,"caption":"Canadian Association for HIV Research"},"image":{"@id":"https:\/\/www.cahr-acrv.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch","https:\/\/x.com\/CAHR_ACRV","https:\/\/bsky.app\/profile\/cahr-acrv.bsky.social","https:\/\/www.youtube.com\/user\/CAHRACRV","https:\/\/www.instagram.com\/cahr_acrv\/","https:\/\/www.linkedin.com\/company\/canadian-association-for-hiv-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/virtual_conferences\/11475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/virtual_conferences"}],"about":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/types\/virtual_conferences"}],"version-history":[{"count":0,"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/virtual_conferences\/11475\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/media?parent=11475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}